研究单位：[1]Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.[2]Peking University Third Hospital,Beijing,Beijing,China,100191[3]Chongqing University Hospital,Chongqing,Chongqing,China,400030[4]The First Affiliated Hospital of Xiamen University,Xiamen,Fujian,China,361003[5]Gansu Provincial Cancer Hospital,Lanzhou,Gansu,China,730050[6]Guangxi Medical University Cancer Hospital,Nanning,Guangxi,China,530021[7]The Affiliated Hospital of Chengde Medical College,Chengde,Hebei,China,067000[8]The Second Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,China,150001[9]Affiliated Cancer Hospital of Harbin Medical University,Harbin,Heilongjiang,China,150081[10]Henan Cancer Hospital,Zhengzhou,Henan,China,450000[11]Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology,Wuhan,Hubei,China,430050[12]The Affiliated Hospital of Xuzhou Medical University,Nanjing,Jiangsu,China,220005[13]The Second Affiliated Hospital of Soochow University,Suzhou,Jiangsu,China,215004[14]The First Affiliated Hospital Of Soochow University,Suzhou,Jiangsu,China,215006[15]Jinzhou Central Hospital,Wuxi,Jiangsu,China,530031[16]Jilin Cancer Hospital,Changchun,Jilin,China,130012[17]The First Hospital of Jilin University,Changchun,Jilin,China,130022[18]The Second Hospital of Dalian Medical University,Dalian,Liaoning,China,116000[19]Binzhou Medical University Hospital,Binzhou,Shandong,China,256603[20]Linyi People's Hospital,Linyi,Shandong,China,276000[21]Shanghai Huashan Hospital,Shanghai,Shanghai,China,200040[22]Tongji hospital of Tongji University,Shanghai,Shanghai,China,200065[23]Heping Hospital Affiliated to Changzhi Medical College,Changzhi,Shanxi,China,046000[24]The Affiliated Hospital of Southwest Medical University,Luzhou,Sichuan,China,646000[25]Tianjin Medical University Cancer Institute and Hospital,Tianjin,Tianjin,China,300040[26]Institute of Dematology & Blood diseases Hospital,Tianjin,Tianjin,China,300052[27]Xinjiang Uygur Autonomous Region People's Hospital,Ürümqi,Xinjiang,China,830001[28]The First Affiliated Hospital, Zhejiang University School of Medicine,Hangzhou,Zhejiang,China,310003[29]The First Affiliated Hospital of Ningbo University,Ningbo,Zhejiang,China,215006
研究目的：
This is a study to assess the safety of TQB3909 monotherapy in participants with relapsed or refractory MCL.
